Terms: = Cervical cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
5 results:
1. Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer.
Huang H; Nie CP; Liu XF; Song B; Yue JH; Xu JX; He J; Li K; Feng YL; Wan T; Zheng M; Zhang YN; Ye WJ; Li JD; Li YF; Li JY; Cao XP; Liu ZM; Zhang XS; Liu Q; Zhang X; Liu JH; Li J
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35727633
[TBL] [Abstract] [Full Text] [Related]
2. Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.
Horikawa N; Baba T; Matsumura N; Murakami R; Abiko K; Hamanishi J; Yamaguchi K; Koshiyama M; Yoshioka Y; Konishi I
BMC Cancer; 2015 Oct; 15():739. PubMed ID: 26482555
[TBL] [Abstract] [Full Text] [Related]
3. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract] [Full Text] [Related]
4. Cellular changes in HeLa cells and cervix cells after treatment with cyclic nucleotides.
Busse E; Zimmer G; Bartsch O; Kornhuber B
Oncology; 1993; 50(4):241-4. PubMed ID: 8388554
[TBL] [Abstract] [Full Text] [Related]
5. Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic gmp: a potential marker for cancer treatment.
Turner GA; Ellis RD; Guthrie D; Latner AL; Monaghan JM; Ross WM; Skillen AW; Wilson RG
J Clin Pathol; 1982 Aug; 35(8):800-6. PubMed ID: 6286732
[TBL] [Abstract] [Full Text] [Related]
